RHC Survey Regarding Interest in COVID-19 Therapeutics

Date: February 25, 2022

The Health Resources and Services Administration (HRSA) is considering adding a limited supply of antiviral drugs to the suite of HRSA direct supply programs for Rural Health Clinics (RHCs) to treat clinically eligible patients who test positive for COVID-19!

In order to gauge RHC interest and need for therapeutics, HRSA is requesting that RHCs complete the brief, 5-question survey found here by 11:59 p.m. your local time on Tuesday, March 2.

As a reminder, RHCs can enroll in the ongoing RHC Test Supply Program to obtain direct access to free at-home test kits, N95 masks, and point of care testing supplies via the DPOP system. You can find directions for enrolling here.

Completing this survey does not enroll your RHC in this program should supplies become available and is only intended to gauge interest and need.

If you have any questions, please contact RHCcovidsupplies@narhc.org. Thank you for your participation!